Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study

• Main Authors: Hsiangkuo Yuan (Author), Fred Cohen (Author), Maurice T Driessen (Author), Lynda J Krasenbaum (Author), Mario Ortega (Author), Mary Hopkins (Author), Michael J Marmura (Author)
• Format: Book
• Published: SAGE Publishing, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Concomitant fremanezumab, a calcitonin gene-related peptide (CGRP) pathway monoclonal antibody (mAb), and onabotulinumtoxinA (onabotA) improve treatment response compared with onabotA alone in patients with chronic migraine (CM). Methods: This was a single-center, retrospective, observat...